Whole Slide Imaging Market to Reach US$ 1,471.71 by 2028

According to our latest study on "Whole Slide Imaging Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Type, Application, and End User," the market is expected to grow from US$ 459.36 million in 2021 to US$ 1,471.71 by 2028; it is estimated to grow at a CAGR of 18.2% from 2022 to 2028.

The report highlights the key factors driving the market and prominent players with their developments in the market. Key factors driving the market are technological advancements and increase in adoption of digital pathology. However, the high cost associated with installation and maintenance restricts the market growth.

Get sample PDF copy @ https://www.theinsightpartners.com/sample/TIPRE00007740/?utm_source=OpenPR&utm_medium=10381

Key Players : 3DHISTECH Ltd.; Indica Labs; Inspirata, Inc.; Koninklijke Philips N.V.; Hamamatsu Photonics K.K.; Olympus; Nikon; Danaher (Leica Biosystems); Mikroscan Technologies, Inc.; Visiopharm AS; and Akoya Biosciences, Inc. are a few of the leading companies in the whole slide imaging market.

The report segments the whole slide imaging market as follows:
The whole slide imaging market, based on type, is segmented into hardware, software, and service. The market for the hardware segment is subsegmented into scanners, microscopes, and cameras. The hardware segment held the largest share of the market in 2021 and is estimated to register the highest CAGR of 18.8% in the market during the forecast period.

Based on application, the whole slide imaging market is segmented into telepathology, cytopathology, immunohistochemistry, and hematopathology. The telepathology segment held the largest share of the market in 2021. However, the immunohistochemistry segment is estimated to register the highest CAGR in the market during the forecast period. The telepathology refers to the practice of pathology from distance with the help of advanced telecommunication software and services.

By end user, the whole slide imaging market is segmented into hospital, pharmaceutical and biopharmaceutical companies, laboratories, and academic research institute. The academic research institute segment held the largest share of the market in 2021. However, the pharmaceutical and biopharmaceutical companies segment is estimated to register the highest CAGR in the market during the forecast period. The academic research institutes held the largest market share owing to the increasing number of academic research centers across the world.

Based on geography, the whole slide imaging market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Speak to Analyst @ https://www.theinsightpartners.com/speak-to-analyst/TIPRE00007740/?utm_source=OpenPR&utm_medium=10381

There is an increasing interest in using whole slide imaging (WSI) for diagnostic purposes (primary and/or consultation). Validation of WSI is crucial to ensure that diagnostic performance based on digitized slides is at least equivalent to that of glass slides and light microscopy. The US Food and Drug Administration (FDA) has approved select digital whole slide imaging (WSI) systems for primary diagnoses in surgical pathology, ushering in new applications for digital pathology. Increasing emphasis on achieving better diagnostic outcomes drives the demand for digital pathologies. The acceptance of digital pathology and whole slide imaging is growing among academic health centers, pathology departments, and the nation's largest pathology companies. Many private practice pathology groups in the US recognize that digital pathology is the path forward for the entire profession. Most academic pathology departments and large pathology lab companies have integrated digital pathology (DP) and whole slide imaging (WSI) into many daily activities in their labs. Rise in technological advancements and increase in digital pathology adoption propel the growth of the whole slide imaging market.

The COVID-19 pandemic is projected to generate lucrative opportunities for digital pathology platforms in the North America region, as shelter-in-place orders are pushing conventional anatomic pathologists to review digital images of patients from the safety of their homes while maintaining accuracy in diagnostics. The digital pathology market is generating attractive opportunities in terms of research for cancer treatments and personalized medicines. The pandemic provides impetus to the market growth, as clinics, hospitals, and CROs are adopting whole slide imaging. The COVID-19 outbreak is likely to result in several permanent changes in the healthcare sector. The digital pathology devices and platforms will play major role to solve the shortage of anatomical pathologists. With other lab medicine disciplines, the COVID-19 pandemic had a surprising impact on histology and digital pathology. Thus, histology labs are receiving the difficult tissue samples to process. There was also a workforce shortage, as more pathologists were retiring than entering the field, and many pathologists were staying out of the lab due to physical distancing requirements. On January 2020, the US Department of Health & Human Services (HHS) issued a public health emergency declaration related to COVID-19 and mobilized HHS's operating divisions. Moreover, the US Centers for Medicare and Medicaid Services (CMS) regulations under CLIA restricted pathologists from making primary diagnoses remotely. As per the rules, pathologists are required to work within clinical laboratories, hospitals, and other healthcare settings holding a CLIA license.

Buy a Complete Report @ https://www.theinsightpartners.com/buy/TIPRE00007740/?utm_source=OpenPR&utm_medium=10381

Contact US
Contact Person : Ankit Mathur
Phone : +1-646-491-9876
E-mail : sales@theinsightpartners.com

About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

This release was published on openPR.